The first fullerene (C60) immunoconjugates have been prepared and characterized as an initial step toward the development of fullerene immunotherapy (FIT). © The Royal Society of Chemistry 2006.
CITATION STYLE
Ashcroft, J. M., Tsyboulski, D. A., Hartman, K. B., Zakharian, T. Y., Marks, J. W., Weisman, R. B., … Wilson, L. J. (2006). Fullerene (C60) immunoconjugates: Interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody. Chemical Communications, (28), 3004–3006. https://doi.org/10.1039/b601717g
Mendeley helps you to discover research relevant for your work.